- Home
- SBEV vs ATHE Comparison
SBEV vs ATHE Comparison
Compare SBEV & ATHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBEV
- ATHE
- Stock Information
- Founded
- SBEV 1992
- ATHE 1997
- Country
- SBEV United States
- ATHE Australia
- Employees
- SBEV N/A
- ATHE N/A
- Industry
- SBEV Beverages (Production/Distribution)
- ATHE Biotechnology: Pharmaceutical Preparations
- Sector
- SBEV Consumer Staples
- ATHE Health Care
- Exchange
- SBEV Nasdaq
- ATHE Nasdaq
- Market Cap
- SBEV 11.4M
- ATHE 10.1M
- IPO Year
- SBEV N/A
- ATHE N/A
- Fundamental
- Price
- SBEV $0.16
- ATHE $2.20
- Analyst Decision
- SBEV Strong Buy
- ATHE Strong Buy
- Analyst Count
- SBEV 2
- ATHE 2
- Target Price
- SBEV $0.75
- ATHE $6.00
- AVG Volume (30 Days)
- SBEV 404.4K
- ATHE 121.1K
- Earning Date
- SBEV 11-15-2024
- ATHE 02-15-2025
- Dividend Yield
- SBEV N/A
- ATHE N/A
- EPS Growth
- SBEV N/A
- ATHE N/A
- EPS
- SBEV N/A
- ATHE N/A
- Revenue
- SBEV $6,257,725.00
- ATHE $2,681,669.00
- Revenue This Year
- SBEV N/A
- ATHE N/A
- Revenue Next Year
- SBEV $182.15
- ATHE N/A
- P/E Ratio
- SBEV N/A
- ATHE N/A
- Revenue Growth
- SBEV N/A
- ATHE 2.63
- 52 Week Low
- SBEV $0.14
- ATHE $1.00
- 52 Week High
- SBEV $0.73
- ATHE $3.19
- Technical
- Relative Strength Index (RSI)
- SBEV 35.51
- ATHE 64.85
- Support Level
- SBEV $0.15
- ATHE $2.04
- Resistance Level
- SBEV $0.17
- ATHE $2.45
- Average True Range (ATR)
- SBEV 0.02
- ATHE 0.23
- MACD
- SBEV -0.00
- ATHE -0.00
- Stochastic Oscillator
- SBEV 12.91
- ATHE 71.15
About SBEV Splash Beverage Group Inc. (NV)
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.